Stocks · Health care · Pharmaceutical Preparations

ARS Pharmaceuticals, Inc.

SPRY Clue Score36

United States Fiscal year ends December CIK 0001671858 Results filed 5 Nov 2026

Add to watchlist

By person

11 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Justin Chakma

Chief Business Officer

—

$1.48M (2) scheduled

−$1.48M

0.0000%

$0.00

−100.0%

Eric Karas

Chief Commercial Officer

—

$250.00K (1) scheduled

−$250.00K

12,176

0.0122%

$121.76K

0.0%

Brian Dorsey

Chief Operating Officer

—

$190.05K (1) scheduled

−$190.05K

10,789

0.0108%

$107.89K

0.0%

Alexander A Fitzpatrick

Chief Legal Officer

—

$33.55K (1) scheduled

−$33.55K

90,910

0.0914%

$909.10K

−6.5%

Richard E Lowenthal

President and CEO

—

5,523,683

5.55%

$55.24M

−6.9%

James E Flynn

10% owner

—

4,887,254

4.91%

$48.87M

−21.1%

Sarina Tanimoto

Chief Medical Officer

—

4,680,959

4.71%

$46.81M

−8.1%

Pratik Shah

Director

—

4,474,554

4.50%

$44.75M

−7.3%

Laura Shawver

Director

—

210,346

0.2115%

$2.10M

0.0%

Kathleen D. Scott

Chief Financial Officer

—

10,042

0.0101%

$100.42K

0.0%

Brent L Saunders

Director

—

0.0000%

$0.00

—

ARS Pharmaceuticals, Inc.

What the insiders did Scheduled selling only

By person